Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
10,370
Employees10,370
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
10,370
Employees10,370

ILMN Key Statistics

Market cap
14.67B
Market cap14.67B
Price-Earnings ratio
12.09
Price-Earnings ratio12.09
Dividend yield
Dividend yield
Average volume
1.58M
Average volume1.58M
High today
$96.78
High today$96.78
Low today
$94.20
Low today$94.20
Open price
$95.20
Open price$95.20
Volume
1.07M
Volume1.07M
52 Week high
$156.66
52 Week high$156.66
52 Week low
$68.70
52 Week low$68.70

ILMN News

Simply Wall St 8h
What Illumina's 5-Base Sequencing Launch Means for Shareholders

At the recent American Society of Human Genetics conference in Boston, Illumina unveiled its novel 5-base sequencing solution and announced that GeneDx is pilot...

What Illumina's 5-Base Sequencing Launch Means for Shareholders
Barron's 3d
Roche Sets Gene-Sequencing Record. It’s a Challenge for Illumina.

Biotech and Pharma Roche Sets Gene-Sequencing Record. It’s a Challenge for Illumina. In this article ROG ILMN This week, the Broad Institute gene-sequencing lab...

Roche Sets Gene-Sequencing Record. It’s a Challenge for Illumina.
TipRanks 4d
Illumina releases its novel 5-base solution

Illumina (ILMN) announced the release of its novel 5-base solution, enabling researchers to pursue broader biological questions with accuracy and ease. The 5-ba...

Analyst ratings

48%

of 23 ratings
Buy
39.1%
Hold
47.8%
Sell
13%

More ILMN News

Simply Wall St 6d
Illumina: Exploring Valuation After BioInsight Launch and Renewed Strategic Ambitions

Illumina (ILMN) has launched BioInsight, a new business unit focused on integrating sequencing, software, and artificial intelligence to tackle large-scale mult...

Illumina: Exploring Valuation After BioInsight Launch and Renewed Strategic Ambitions

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.